Salusin-β Contributes to Vascular Remodeling Associated with Hypertension Via Promoting Vascular Smooth Muscle Cell Proliferation and Vascular Fibrosis
Overview
Biophysics
Authors
Affiliations
Vascular smooth muscle cell (VSMC) proliferation and vascular fibrosis are closely linked with hypertension and atherosclerosis. Salusin-β is a bioactive peptide involved in the pathogenesis of atherosclerosis. However, it is still largely undefined whether salusin-β is a potential candidate in the VSMC proliferation and vascular fibrosis. Experiments were carried out in human vascular smooth muscle cells (VSMCs) and in rats with intravenous injection of lentivirus expressing salusin-β. In vitro, salusin-β promoted VSMCs proliferation, which was attenuated by adenylate cyclase inhibitor SQ22536, PKA inhibitor Rp-cAMP, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478, ERK inhibitor U0126 or cAMP response element binding protein (CREB) inhibitor KG501. It promoted the phosphorylation of ERK1/2, CREB and EGFR, which were abolished by SQ22536 or Rp-cAMP. Furthermore, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 diminished the salusin-β-evoked ERK1/2 and CREB phosphorylation. On the other hand, salusin-β increased collagen-I, collagen-III, fibronectin and connective tissue growth factor (CTGF) mRNA and phosphorylation of Smad2/3, which were prevented by ALK5 inhibitor A83-01. In vivo, salusin-β overexpression increased the media thickness, media/lumen ratio coupled with ERK1/2, CREB, EGFR and Smad2/3 phosphorylation, as well as the mRNA of collagen-I, collagen-III, fibronectin, transforming growth factor-β1 (TGF-β1) and CTGF in arteries. Moreover, salusin-β overexpression in rats caused severe hypertension. Intravenous injection of salusin-β dose-relatedly increased blood pressure, but excessive salusin-β decreased blood pressure and heart rate. These results indicate that salusin-β promotes VSMC proliferation via cAMP-PKA-EGFR-CREB/ERK pathway and vascular fibrosis via TGF-β1-Smad pathway. Increased salusin-β contributes to vascular remodeling and hypertension.
Dang J, Zhang W, Chu Y, Chen J, Ji Z, Feng P Eur J Med Res. 2024; 29(1):109.
PMID: 38336819 PMC: 10854150. DOI: 10.1186/s40001-024-01676-z.
An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed.
Hua R, Gao H, He C, Xin S, Wang B, Zhang S Front Cardiovasc Med. 2024; 10:1273502.
PMID: 38179503 PMC: 10764515. DOI: 10.3389/fcvm.2023.1273502.
Serum salusin-β levels in patients with systemic lupus erythematosus.
Hajialilo M, Jorjani R, Rahimi M, Ghorbanihaghjo A, Malek Mahdavi A, Ghojazadeh M Clin Rheumatol. 2023; 42(8):2097-2103.
PMID: 37120490 DOI: 10.1007/s10067-023-06610-y.
The Clinical Significance of Salusins in Systemic Sclerosis-A Cross-Sectional Study.
Nowaczyk J, Blicharz L, Zawistowski M, Sikora M, Zaremba M, Czuwara J Diagnostics (Basel). 2023; 13(5).
PMID: 36899991 PMC: 10001236. DOI: 10.3390/diagnostics13050848.
Sodium Nitroprusside Stimulation of Elastic Matrix Regeneration by Aneurysmal Smooth Muscle Cells.
Bastola S, Kothapalli C, Ramamurthi A Tissue Eng Part A. 2023; 29(7-8):225-243.
PMID: 36597287 PMC: 10122248. DOI: 10.1089/ten.TEA.2022.0169.